The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapy
Open accessAbstract
The use of visible light to produce highly selective and potent drugs through photodynamic therapy (PDT) holds much potential in the treatment of cancer. PDT agents can be designed to follow an O2-dependent mechanism by producing highly reactive species such as 1O2 and/or an O2 independent mechanism through processes such as excited state electron transfer, covalent binding to DNA or photoinduced drug delivery. Ru(II)-polypyridyl and Rh2(II,II) complexes represent an important class of compounds that can be tailored to exhibit desired photophysical properties and photochemical reactivity by judicious selection of the ligand set. Complexes with relatively long-lived excited states and planar, intercalating ligands localize on the DNA strand and photocleave DNA through 1O2 production or guanine oxidation by the excited state of the chromophore. Photoinduced ligand substitution occurs through the population of triplet metal centered (3MC) excited states and facilitates covalent binding of the metal complex to DNA in a mode similar to cisplatin. Ligand photodissociation also provides a route to selective drug delivery. The ability to construct metal complexes with desired light absorbing and excited state properties by ligand variation enables the design of PDT agents that can potentially provide combination therapy from a single metal complex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Ru(II) polypyridine complexes: photophysics, photochemistry, eletrochemistry, and chemiluminescence
Juris, A., Balzani, V., Barigelletti, F., Campagna, S., Belser, P., & von Zelewsky, A. (1988) · Coordination Chemistry Reviews · doi:10.1016/0010-8545(88)80032-8 · Cited by 4,862
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., & Walter, P. (2007) · W.W. Norton eBooks · doi:10.1201/9780203833445 · Cited by 4,589
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
Spheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742
A molecular light switch for DNA: Ru(bpy)2(dppz)2+
Friedman, A. E., Chambron, J. C., Sauvage, J. P., Turro, N. J., & Barton, J. K. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00168a052 · Cited by 1,412
Cited by
New photosensitizers for photodynamic therapy
Abrahamse, H., & Hamblin, M. R. (2016) · Biochemical Journal · doi:10.1042/bj20150942 · Cited by 2,033
Monro, S., Colón, K. L., Yin, H., Roque, J., Konda, P., Gujar, S., Thummel, R. P., Lilge, L., Cameron, C. G., & McFarland, S. A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00211 · Cited by 1,461
Zhao, X., Liu, J., Fan, J., Chao, H., & Peng, X. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00173b · Cited by 1,270
Zeng, L., Gupta, P., Chen, Y., Wang, E., Ji, L., Chao, H., & Chen, Z.-S. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00195a · Cited by 1,017
Spin-Vibronic Mechanism for Intersystem Crossing
Penfold, T. J., Gindensperger, E., Daniel, C., & Marian, C. M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00617 · Cited by 978
Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials
Weinstain, R., Slanina, T., Kand, D., & Klán, P. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00663 · Cited by 642
Heinemann, F., Karges, J., & Gasser, G. (2017) · Accounts of Chemical Research · doi:10.1021/acs.accounts.7b00180 · Cited by 611
Targeted photoredox catalysis in cancer cells
Huang, H., Banerjee, S., Qiu, K., Zhang, P., Blacque, O., Malcomson, T., Paterson, M. J., Clarkson, G. J., Staniforth, M., Stavros, V. G., et al. (2019) · Nature Chemistry · doi:10.1038/s41557-019-0328-4 · Cited by 539
A Mitochondria‐Targeted Photosensitizer Showing Improved Photodynamic Therapy Effects Under Hypoxia
Lv, W., Zhang, Z., Zhang, K. Y., Yang, H., Liu, S., Xu, A., Guo, S., Zhao, Q., & Huang, W. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201604130 · Cited by 523
Huang, H., Yu, B., Zhang, P., Huang, J., Chen, Y., Gasser, G., Ji, L., & Chao, H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201507800 · Cited by 449
Transition metal complexes as photosensitisers in one- and two-photon photodynamic therapy
McKenzie, L. K., Bryant, H. E., & Weinstein, J. A. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.03.020 · Cited by 431
Poynton, F. E., Bright, S. A., Blasco, S., Williams, D. C., Kelly, J. M., & Gunnlaugsson, T. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00680b · Cited by 421
Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives
Lee, S. Y., Kim, C. Y., & Nam, T.-G. (2020) · Drug Design, Development and Therapy · doi:10.2147/dddt.s275007 · Cited by 400
Recent Advances in Subcellular Targeted Cancer Therapy Based on Functional Materials
Chen, W., Luo, G., & Zhang, X. (2019) · Advanced Materials · doi:10.1002/adma.201802725 · Cited by 373
Type I photodynamic therapy by organic–inorganic hybrid materials: From strategies to applications
Wang, Y.-Y., Liu, Y.-C., Sun, H., & Guo, D.-S. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.05.016 · Cited by 344
Photocontrol of Antibacterial Activity: Shifting from UV to Red Light Activation
Wegener, M., Hansen, M. J., Driessen, A. J. M., Szymanski, W., & Feringa, B. L. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b09281 · Cited by 324
Rationally designed ruthenium complexes for 1- and 2-photon photodynamic therapy
Karges, J., Kuang, S., Maschietto, F., Blacque, O., Ciofini, I., Chao, H., & Gasser, G. (2020) · Nature Communications · doi:10.1038/s41467-020-16993-0 · Cited by 284
Molecular photosensitisers for two-photon photodynamic therapy
Bolze, F., Jenni, S., Sour, A., & Heitz, V. (2017) · Chemical Communications · doi:10.1039/c7cc06133a · Cited by 273
Kuang, S., Wei, F., Karges, J., Ke, L., Xiong, K., Liao, X., Gasser, G., Ji, L., & Chao, H. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c13137 · Cited by 271
The concept and examples of type-III photosensitizers for cancer photodynamic therapy
Yao, Q., Fan, J., Long, S., Zhao, X., Li, H., Du, J., Shao, K., & Peng, X. (2022) · Chem · doi:10.1016/j.chempr.2021.10.006 · Cited by 256
Metadata
- Authors
- Knoll, J. D., & Turro, C.
- Venue
- Coordination Chemistry Reviews
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 282-283
- Pages
- 110-126
- ISSN
- 0010-8545 (ISSN-L)
- OpenAlex
- W2112927475
- Cited by
- 423
- References
- 79
- FWCI
- 17.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.